Changes in coagulation and fibrinolysis in horses during exercise

Kenneth H. McKeever From the Department of Veterinary Clinical Sciences, Department of Veterinary Physiology and Pharmacology, and Department of Veterinary Pathobiology, The Ohio State University, Columbus, OH 43210.

Search for other papers by Kenneth H. McKeever in
Current site
Google Scholar
PubMed
Close
 PhD
,
Kenneth W. Hinchcliff From the Department of Veterinary Clinical Sciences, Department of Veterinary Physiology and Pharmacology, and Department of Veterinary Pathobiology, The Ohio State University, Columbus, OH 43210.

Search for other papers by Kenneth W. Hinchcliff in
Current site
Google Scholar
PubMed
Close
 BVSc, MS
,
Gary J. Kociba From the Department of Veterinary Clinical Sciences, Department of Veterinary Physiology and Pharmacology, and Department of Veterinary Pathobiology, The Ohio State University, Columbus, OH 43210.

Search for other papers by Gary J. Kociba in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Stephen M. Reed From the Department of Veterinary Clinical Sciences, Department of Veterinary Physiology and Pharmacology, and Department of Veterinary Pathobiology, The Ohio State University, Columbus, OH 43210.

Search for other papers by Stephen M. Reed in
Current site
Google Scholar
PubMed
Close
 DVM
, and
William W. Muir III From the Department of Veterinary Clinical Sciences, Department of Veterinary Physiology and Pharmacology, and Department of Veterinary Pathobiology, The Ohio State University, Columbus, OH 43210.

Search for other papers by William W. Muir III in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Click on author name to view affiliation information

SUMMARY

Changes in clotting time (ct) and fibrinolytic actvity (fa) were evaluated in 6 mature, female horses during exercise. Two trials were performed on consecutive days, using a randomized crossover design. Each mare was assigned to either an exercise trial or a control trial on the first day, and to the alternate trial 24 hours later. Mares exercised for 20 minutes on a treadmill at an elevation of 2° and a velocity of 5 m/s. Venous blood samples were collected immediately before exercise, at 4, 8, 12, 16, and 20 minutes during exercise, and 15 minutes after cessation of exercise. Blood was placed into plain glass tubes for determination of CT, and into chilled, citrated tubes for determination of FA, plasminogen/plasmin complex activity (plg), one-stage prothrombin time (ospt), activated partial thromboplastin time (aptt), and antithrombin-III (at-III) activity. There were significant differences (P < 0.05) between the control and exercise groups for ct, fa, and plg. During exercise, clotting time decreased from 21.5 ± 1.6 minutes to 9.9 ± 1.6 minutes (mean ± sd; P < 0.05), without significant changes in ospt, aptt, or at-III. Fibrinolytic activity and plg increased (P < 0.05) during exercise. Changes in ct, fa, and plg were significant at 4 minutes of exercise, remained altered until the end of exercise, and returned to baseline values by 45 minutes of recovery. Clotting time, ospt, aptt, fa, at-III, and plg did not change (P > 0.05) during control trials.

SUMMARY

Changes in clotting time (ct) and fibrinolytic actvity (fa) were evaluated in 6 mature, female horses during exercise. Two trials were performed on consecutive days, using a randomized crossover design. Each mare was assigned to either an exercise trial or a control trial on the first day, and to the alternate trial 24 hours later. Mares exercised for 20 minutes on a treadmill at an elevation of 2° and a velocity of 5 m/s. Venous blood samples were collected immediately before exercise, at 4, 8, 12, 16, and 20 minutes during exercise, and 15 minutes after cessation of exercise. Blood was placed into plain glass tubes for determination of CT, and into chilled, citrated tubes for determination of FA, plasminogen/plasmin complex activity (plg), one-stage prothrombin time (ospt), activated partial thromboplastin time (aptt), and antithrombin-III (at-III) activity. There were significant differences (P < 0.05) between the control and exercise groups for ct, fa, and plg. During exercise, clotting time decreased from 21.5 ± 1.6 minutes to 9.9 ± 1.6 minutes (mean ± sd; P < 0.05), without significant changes in ospt, aptt, or at-III. Fibrinolytic activity and plg increased (P < 0.05) during exercise. Changes in ct, fa, and plg were significant at 4 minutes of exercise, remained altered until the end of exercise, and returned to baseline values by 45 minutes of recovery. Clotting time, ospt, aptt, fa, at-III, and plg did not change (P > 0.05) during control trials.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 31 31 4
PDF Downloads 70 70 1
Advertisement